The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Paraneoplastic anti– N ‐methyl‐ D ‐aspartate receptor encephalitis associated with ovarian teratoma
Open accessAbstract
OBJECTIVE: To report the autoantigens of a new category of treatment-responsive paraneoplastic encephalitis. METHODS: Analysis of clinical features, neuropathological findings, tumors, and serum/cerebrospinal fluid antibodies using rat tissue, neuronal cultures, and HEK293 cells expressing subunits of the N-methyl-D-aspartate receptor (NMDAR). RESULTS: Twelve women (14-44 years) developed prominent psychiatric symptoms, amnesia, seizures, frequent dyskinesias, autonomic dysfunction, and decreased level of consciousness often requiring ventilatory support. All had serum/cerebrospinal fluid antibodies that predominantly immunolabeled the neuropil of hippocampus/forebrain, in particular the cell surface of hippocampal neurons, and reacted with NR2B (and to a lesser extent NR2A) subunits of the NMDAR. NR2B binds glutamate and forms heteromers (NR1/NR2B or NR1/NR2A/NR2B) that are preferentially expressed in the adult hippocampus/forebrain. Expression of functional heteromers (not single subunits) was required for antibody binding. Eleven patients had teratoma of the ovary (six mature) and one a mature teratoma in the mediastinum; five of five tumors examined contained nervous tissue that strongly expressed NR2 subunits and reacted with patients' antibodies. Tumor resection and immunotherapy resulted in improvement or full recovery of eight of nine patients (paralleled by decreased antibody titers); two of three patients without tumor resection died of neurological deterioration. Autopsies showed extensive microgliosis, rare T-cell infiltrates, and neuronal degeneration predominantly involving, but not restricted to, the hippocampus. INTERPRETATION: Antibodies to NR2B- and NR2A-containing heteromers of the NMDAR associate with a severe but treatment-responsive encephalitis. Our findings provide a diagnostic test and suggest a model of autoimmune NMDAR-related encephalitis with broad implications for other immune-mediated disorders of memory, behavior, and cognition.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Preliminary studies suggested the target epitopes were located in extracellular regions of NR1–NR2B NMDA receptors.5”
From Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies (2008) · cites this paper as [5]
In the citing paper
“We recently identified a disorder, designated anti-NMDA-receptor encephalitis, that associates with antibodies against NR1–NR2 heteromers and results in a characteristic neuropsychiatric syndrome.5”
From Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies (2008) · cites this paper as [5]
In the citing paper
“The first patients identified were young women with ovarian teratoma who presented with psychosis or memory problems, rapidly progressing to multiple neurological deficits requiring prolonged intensive care support.”
From Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies (2008) · cites this paper as [5]
In the citing paper
“Serum and CSF were tested for antibodies against the NMDA receptor,5 and considered positive if three immunohistochemical criteria were fulfilled (figure 1).”
From Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies (2008) · cites this paper as [5]
In the citing paper
“Despite the severity of the disorder, patients often recovered after tumour removal and immunotherapy, suggesting an immune-mediated pathogenesis.”
From Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies (2008) · cites this paper as [5]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Monyer, H., Burnashev, N., Laurie, D. J., Sakmann, B., & Seeburg, P. H. (1994) · Neuron · doi:10.1016/0896-6273(94)90210-0 · Cited by 3,535
Gultekin, S. H. (2000) · Brain · doi:10.1093/brain/123.7.1481 · Cited by 1,110
Anti-Hu-associated paraneoplastic encephalomyelitis: analysis of 200 patients
Graus, F. (2001) · Brain · doi:10.1093/brain/124.6.1138 · Cited by 891
DeGiorgio, L. A., Konstantinov, K. N., Lee, S. C., Hardin, J., Volpe, B. T., & Diamond, B. (2001) · Nature Medicine · doi:10.1038/nm1101-1189 · Cited by 798
Clinical analysis of anti-Ma2-associated encephalitis
Dalmau, J. O. (2004) · Brain · doi:10.1093/brain/awh203 · Cited by 776
Antigen unmasking on formalin‐fixed, paraffin‐embedded tissue sections
Cattoretti, G., Pileri, S. A., Parravicini, C., Becker, M. H. G., Poggi, S., Bifulco, C. B., Key, G., D'Amato, L., Sabattini, E., Feudale, E. A. A., et al. (1993) · The Journal of Pathology · doi:10.1002/path.1711710205 · Cited by 721
Paraneoplastic encephalitis, psychiatric symptoms, and hypoventilation in ovarian teratoma
Vitaliani, R., Mason, W. P., Ances, B. M., Zwerdling, T., Jiang, Z., & Dalmau, J. O. (2005) · Annals of Neurology · doi:10.1002/ana.20614 · Cited by 604
Treatment-responsive limbic encephalitis identified by neuropil antibodies: MRI and PET correlates
Ances, B. M., Vitaliani, R., Taylor, R. A., Liebeskind, D. S., Voloschin, A. D., Houghton, D. J., Galetta, S. L., Dichter, M. A., Alavi, A. A., Rosenfeld, M. R., et al. (2005) · Brain · doi:10.1093/brain/awh526 · Cited by 486
Laube, B., Hirai, H., Sturgess, M., Betz, H., & Kuhse, J. (1997) · Neuron · doi:10.1016/s0896-6273(00)81249-0 · Cited by 476
Wenzel, A., Fritschy, J., Möhler, H., & Benke, D. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.68020469.x · Cited by 442
Cited by
Sorted by citations
Items 301–400 of 1,000
A novel treatment‐responsive encephalitis with frequent opsoclonus and teratoma
Armangué, T., Titulaer, M. J., Sabater, L., Moreno, J. P., Gresa‐Arribas, N., Barbero-Bordallo, N., Kelley, G. R., Noh, K., Takeda, A., Nagao, T., et al. (2013) · Annals of Neurology · doi:10.1002/ana.23917 · Cited by 66
Anti-NR2A antibody as a predictor for neuropsychiatric systemic lupus erythematosus
Gono, T., Kawaguchi, Y., Kaneko, H., Nishimura, K., Hanaoka, M., Kataoka, S., Okamoto, Y., Katsumata, Y., & Yamanaka, H. (2011) · Rheumatology · doi:10.1093/rheumatology/keq408 · Cited by 63
Encefalitis por anticuerpos contra el receptor de NMDA
Guasp, M., & Dalmau, J. O. (2017) · Medicina Clínica · doi:10.1016/j.medcli.2017.10.015 · Cited by 65
Neurologic Autoimmunity in the Era of Checkpoint Inhibitor Cancer Immunotherapy
Ζεκερίδου, Α., & Lennon, V. A. (2019) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2019.02.003 · Cited by 65
Autoantibody diagnostics in clinical practice
Conrad, K., Roggenbuck, D., Reinhold, D., & Sack, U. (2012) · Autoimmunity Reviews · doi:10.1016/j.autrev.2011.05.014 · Cited by 64
Yu, Y., Wu, Y., Cao, X., Li, J., Liao, X., Wei, J., & Huang, W. (2020) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2020.102604 · Cited by 63
Limbic encephalitis associated with anti‐GAD antibody and common variable immune deficiency
Akman, Ç. I., Patterson, M. C., Rubinstein, A., & Herzog, R. (2009) · Developmental Medicine & Child Neurology · doi:10.1111/j.1469-8749.2008.03217.x · Cited by 64
Immunomodulatory Therapies in Neurologic Critical Care
McDaneld, L. M., Fields, J. D., BOURDETTE, D. N., & Bhardwaj, A. (2009) · Neurocritical Care · doi:10.1007/s12028-009-9274-0 · Cited by 62
Zandi, M. S., Deakin, J., Morris, K. A., Buckley, C. J., Jacobson, L. W., Scoriels, L., Cox, A. L., Coles, A. J., Jones, P. B., Vincent, A. C., et al. (2014) · Schizophrenia Research · doi:10.1016/j.schres.2014.11.001 · Cited by 62
Pearls & Oy-sters: Electroconvulsive therapy in anti-NMDA receptor encephalitis
Braakman, H. M. H., Moers-Hornikx, V. M. P., Arts, B. M. G., Hupperts, R., & Nicolai, J. (2010) · Neurology · doi:10.1212/wnl.0b013e3181f11dc1 · Cited by 63
Neuropathology of autoimmune encephalitides
Bauer, J., & Bien, C. G. (2016) · Handbook of clinical neurology · doi:10.1016/b978-0-444-63432-0.00007-4 · Cited by 63
Scott, J. G., Gillis, D., Ryan, A., Hargovan, H., Gundarpi, N., McKeon, G. L., Hatherill, S., Newman, M., Parry, P. I., Prain, K. M., et al. (2018) · BJPsych Open · doi:10.1192/bjo.2018.8 · Cited by 62
Qiu, X., Zhang, H., Li, D., Wang, J., Jiang, Z., Zhou, Y., Xu, P., Zhang, J., Feng, Z., Yu, C., et al. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01286 · Cited by 64
Leucine Zipper 4 Autoantibody: A Novel Germ Cell Tumor and Paraneoplastic Biomarker
Dubey, D., Kryzer, T. J., Guo, Y., Clarkson, B. D. S., Cheville, J. C., Costello, B. A., Leibovich, B. C., Algeciras‐Schimnich, A., Lucchinnetti, C., Hammami, M. B., et al. (2021) · Annals of Neurology · doi:10.1002/ana.26050 · Cited by 60
Antibody Therapies in Autoimmune Encephalitis
Smets, I., & Titulaer, M. J. (2022) · Neurotherapeutics · doi:10.1007/s13311-021-01178-4 · Cited by 61
Diagnostic value of CSF findings in antibody-associated limbic and anti-NMDAR-encephalitis
Malter, M. P., Elger, C. E., & Surges, R. (2013) · Seizure · doi:10.1016/j.seizure.2012.12.013 · Cited by 61
Kashyape, P. S., Taylor, E., Ng, J., Krishnakumar, D., Kirkham, F. J., & Whitney, A. (2011) · European Journal of Paediatric Neurology · doi:10.1016/j.ejpn.2011.07.005 · Cited by 61
Guan, H., Ren, H., & Cui, L. (2016) · Chinese Medical Journal · doi:10.4103/0366-6999.180514 · Cited by 61
Sinmaz, N., Nguyen, T. T.-T. N., Tea, F., Dale, R. C., & Brilot, F. (2016) · Journal of Neuroinflammation · doi:10.1186/s12974-016-0678-4 · Cited by 62
Suh-Lailam, B. B., Haven, T. R., Copple, S. S., Knapp, D., Jaskowski, T. D., & Tebo, A. E. (2013) · Clinica Chimica Acta · doi:10.1016/j.cca.2013.02.010 · Cited by 58
Lilleker, J. B., Biswas, V., & Mohanraj, R. (2014) · Seizure · doi:10.1016/j.seizure.2014.04.009 · Cited by 60
Adenylate kinase 5 autoimmunity in treatment refractory limbic encephalitis
Tüzün, E., Rossi, J., Karner, S. F., Centurion, A. F., & Dalmau, J. O. (2007) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2007.03.015 · Cited by 60
Changing Brain Metabolism Patterns in Patients With ANMDARE
Yuan, J., Guan, H., Zhou, X., Niu, N., Li, F., Cui, L., & Cui, R. (2016) · Clinical Nuclear Medicine · doi:10.1097/rlu.0000000000001164 · Cited by 60
Paraneoplastic Neurological Syndromes: Unusual Presentations of Cancer. A Practical Review
Braik, T., Evans, A. T., Telfer, M. C., & McDunn, S. H. (2010) · The American Journal of the Medical Sciences · doi:10.1097/maj.0b013e3181d9bb3b · Cited by 60
Abnormalities of Respiratory Control and the Respiratory Motor Unit
Nogués, M. A., & Benarroch, E. E. (2008) · The Neurologist · doi:10.1097/nrl.0b013e318173e830 · Cited by 59
Sartori, S., Nosadini, M., Cesaroni, E., Falsaperla, R., Capovilla, G., Beccaria, F., Mancardi, M. M., Santangelo, G., Giunta, L., Boniver, C., et al. (2015) · European Journal of Paediatric Neurology · doi:10.1016/j.ejpn.2015.02.006 · Cited by 59
Incidence of intracranial germ cell tumors by race in the United States, 1992–2010
Poynter, J. N., Fonstad, R. K., Tolar, J., Spector, L. G., & Ross, J. A. (2014) · Journal of Neuro-Oncology · doi:10.1007/s11060-014-1562-7 · Cited by 58
Malignant catatonia due to anti-NMDA-receptor encephalitis in a 17-year-old girl: case report
Consoli, A., Ronen, K., Gourfinkel‐An, I., Barbeau, M., Marra, D., Costedoat-Chalumeau, N., Montefiore, D., Maksud, P., Bonnot, O., Didelot, A., et al. (2011) · Child and Adolescent Psychiatry and Mental Health · doi:10.1186/1753-2000-5-15 · Cited by 59
Ischemic Stroke Biomarkers in Blood
van der List, L. C., & Jickling, G. C. (2013) · Biomarkers in Medicine · doi:10.2217/bmm.12.104 · Cited by 59
Huang, Q., Wu, Y., Qin, R., Wei, X., & Ma, M. (2016) · Journal of Neurology · doi:10.1007/s00415-016-8282-1 · Cited by 59
Levite, M., & Ganor, Y. (2008) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.8.7.1141 · Cited by 59
Catts, V. S., Derminio, D. S., Hahn, C.-G., & Weickert, C. S. (2015) · npj Schizophrenia · doi:10.1038/npjschz.2015.37 · Cited by 58
NMDAR Antibodies Alter Dopamine Receptors and Cause Psychotic Behavior in Mice
Carceles‐Cordon, M., Mannara, F., Aguilar, E., Castellanos, A., Planagumà, J., & Dalmau, J. O. (2020) · Annals of Neurology · doi:10.1002/ana.25829 · Cited by 60
State of the Art: Acute Encephalitis
Bloch, K. C., Glaser, C. A., Gaston, D. C., & Venkatesan, A. (2023) · Clinical Infectious Diseases · doi:10.1093/cid/ciad306 · Cited by 69
Limbic Encephalitis Associated With GAD65 Antibodies: Brief Review of the Relevant literature
Gagnon, M.-M., & Savard, M. (2016) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/cjn.2016.13 · Cited by 58
Suspected new‐onset autoimmune temporal lobe epilepsy with amygdala enlargement
Malter, M. P., Widman, G., Galldiks, N., Stoecker, W., Helmstaedter, C., Elger, C. E., & Wagner, J. (2016) · Epilepsia · doi:10.1111/epi.13471 · Cited by 58
Autoantibody-associated psychiatric syndromes: a systematic literature review resulting in 145 cases
Endres, D., Maier, V., Leypoldt, F., Wandinger, K., Lennox, B., Pollak, T. A., Nickel, K., Maier, S. J., Feige, B., Domschke, K., et al. (2020) · Psychological Medicine · doi:10.1017/s0033291720002895 · Cited by 59
Vullhorst, D., Mitchell, R. M., Keating, C. E., Roychowdhury, S., Karavanova, I. D., Tao-Cheng, J.-H., & Buonanno, A. (2015) · Nature Communications · doi:10.1038/ncomms8222 · Cited by 58
Wickel, J., Chung, H., Platzer, S., Lehmann, T., Prüß, H., Leypoldt, F., Günther, A., Scherag, A., Geis, C., & on behalf of the GENERATE Study Group (2020) · Trials · doi:10.1186/s13063-020-04516-7 · Cited by 56
Clinical Character of CASPR2 Autoimmune Encephalitis: A Multiple Center Retrospective Study
Qin, X., Yang, H., Zhu, F., Wang, Q., & Shan, W. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.652864 · Cited by 56
Isolated hemidystonia associated with NMDA receptor antibodies
Rubio‐Agusti, I., Dalmau, J. O., Sevilla, T., Burgal, M., Beltrán, E., & Bataller, L. (2010) · Movement Disorders · doi:10.1002/mds.23315 · Cited by 54
Paraneoplastic movement disorders
Grant, R., & Graus, F. (2009) · Movement Disorders · doi:10.1002/mds.22658 · Cited by 54
Vezzani, A., & Rüegg, S. J. (2011) · Epilepsia · doi:10.1111/j.1528-1167.2011.03028.x · Cited by 56
Successful combined targeting of B- and plasma cells in treatment refractory anti-NMDAR encephalitis
Sveinsson, O. A., Granqvist, M., Forslin, Y., Blennow, K., Zetterberg, H., & Piehl, F. (2017) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2017.08.011 · Cited by 55
Encephalitis: diagnosis, management and recent advances in the field of encephalitides
Alam, A. M., Easton, A., Nicholson, T. R., Irani, S. R., Davies, N. W. S., Solomon, T., & Michael, B. D. (2022) · Postgraduate Medical Journal · doi:10.1136/postgradmedj-2022-141812 · Cited by 54
Wang, Y. X., Zhang, W., Yin, J., Lu, Q., Yin, F., He, F. P., & Peng, J. (2017) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2017.09.005 · Cited by 54
Clinical features of seronegative, but CSF antibody-positive, anti-NMDA receptor encephalitis
Guasp, M., Módena, Y., Armangué, T., Dalmau, J. O., & Graus, F. (2020) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000000659 · Cited by 55
Differential Diagnosis of Chorea
Walker, R. H. (2011) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-011-0202-2 · Cited by 54
Encephalitis with Autoantibodies against the Glutamate Kainate Receptors GluK2
Landa, J., Guasp, M., Míguez‐Cabello, F., Guimarães, J., Mishima, T., Oda, F., Zipp, F., Krajinović, V., Fuhr, P., Honnorat, J., et al. (2021) · Annals of Neurology · doi:10.1002/ana.26098 · Cited by 52
Anti-NMDA Receptor Encephalitis in the Polar Bear (Ursus maritimus) Knut
Prüß, H., Leubner, J., Wenke, N. K., Czirják, G. Á., Szentiks, C. A., & Greenwood, A. D. (2015) · Scientific Reports · doi:10.1038/srep12805 · Cited by 53
Current approaches to the treatment of paraneoplastic encephalitis
Grisold, W., Giometto, B., Vitaliani, R., & Oberndorfer, S. (2011) · Therapeutic Advances in Neurological Disorders · doi:10.1177/1756285611405395 · Cited by 53
Outcome of childhood-onset epilepsy from adolescence to adulthood: Transition issues
Nabbout, R., Andrade, D. M., Bahi‐Buisson, N., Cross, J. H., Desquerre, I., Dulac, O., Granata, T., Hirsch, É., Navarro, V., Ouss, L., et al. (2017) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2016.11.010 · Cited by 53
Relapse risk factors in anti‐N‐methyl‐D‐aspartate receptor encephalitis
Nosadini, M., Granata, T., Matricardi, S., Freri, E., Ragona, F., Papetti, L., Suppiej, A., Valeriani, M., Sartori, S., & Italian Working Group on Paediatric Anti‐N‐methyl‐D‐aspartate Receptor Encephalitis (2019) · Developmental Medicine & Child Neurology · doi:10.1111/dmcn.14267 · Cited by 53
Persistent memories of long-term potentiation and the N -methyl-d-aspartate receptor
Bliss, T. V. P., & Collingridge, G. L. (2019) · Brain and Neuroscience Advances · doi:10.1177/2398212819848213 · Cited by 58
Flannery, P. C., Yang, I., Keyvani, M., & Sakoulas, G. (2021) · Frontiers in Neurology · doi:10.3389/fneur.2021.764197 · Cited by 52
Ceangă, M., Rahmati, V., Haselmann, H., Schmidl, L., Hunter, D., Brauer, A.-K., Liebscher, S., Kreye, J., Prüß, H., Groc, L., et al. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.113166 · Cited by 55
Kamei, S., Kuzuhara, S., Ishihara, M., Morita, A., Taira, N., Togo, M., Matsui, M., Ogawa, M., Hisanaga, K., Mizutani, T., et al. (2009) · Internal Medicine · doi:10.2169/internalmedicine.48.1898 · Cited by 52
Paraneoplastic and non-paraneoplastic autoimmunity to neurons in the central nervous system
Melzer, N., Meuth, S. G., & Wiendl, H. (2012) · Journal of Neurology · doi:10.1007/s00415-012-6657-5 · Cited by 52
Paraneoplastic neurological syndromes associated with ovarian tumors
Zaborowski, M. P., Spaczyński, M., Nowak‐Markwitz, E., & Michalak, S. (2014) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-014-1745-9 · Cited by 54
Pathogen-mediated NMDA receptor autoimmunity and cellular barrier dysfunction in schizophrenia
Kannan, G., Gressitt, K. L., Yang, S. Y., Stallings, C. R., Katsafanas, E., Schweinfurth, L. A. B., Savage, C. L. G., Adamos, M. B., Sweeney, K., Origoni, A. E., et al. (2017) · Translational Psychiatry · doi:10.1038/tp.2017.162 · Cited by 53
Anti-NMDA-Receptor Encephalitis: From Bench to Clinic
Venkatesan, A., & Adatia, K. (2017) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.7b00319 · Cited by 55
Autoimmune gait disturbance accompanying adaptor protein-3B2-IgG
Honorat, J. A., Lopez-Chiriboga, A. S., Kryzer, T. J., Komorowski, L., Scharf, M., Hinson, S. R., Lennon, V. A., Pittock, S. J., Klein, C. J., & McKeon, A. B. (2019) · Neurology · doi:10.1212/wnl.0000000000008061 · Cited by 51
Anti-NMDA-Rezeptor-Enzephalitis
Prüß, H., Dalmau, J. O., Arolt, V., & Wandinger, K.-P. (2010) · Der Nervenarzt · doi:10.1007/s00115-009-2908-9 · Cited by 48
NMDA-receptor antibodies alter cortical microcircuit dynamics
Rosch, R. E., Wright, S. K., Cooray, G., Papadopoulou, M., Goyal, S., Lim, M. J., Vincent, A. C., Upton, A. L., Baldeweg, T., & Friston, K. J. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1804846115 · Cited by 48
Psychiatric Presentation of Anti-NMDA Receptor Encephalitis
Endres, D., Rauer, S., Kern, W. V., Venhoff, N., Maier, S. J., Runge, K., Süß, P., Feige, B., Nickel, K., Heidt, T., et al. (2019) · Frontiers in Neurology · doi:10.3389/fneur.2019.01086 · Cited by 52
N‐Methyl‐D‐Aspartate Receptor Antibodies in Autoimmune Encephalopathy Alter Oligodendrocyte Function
Matute, C., Palma, A., Serrano‐Regal, M. P., Maudes, E., Barman, S., Sánchez‐Gómez, M. V., Domercq, M., Goebels, N., & Dalmau, J. O. (2020) · Annals of Neurology · doi:10.1002/ana.25699 · Cited by 50
Endres, D., von Zedtwitz, K., Matteit, I., Bünger, I., Rasmussen, H. F., Runge, K., Feige, B., Schlump, A., Maier, S. J., Nickel, K., et al. (2022) · Biological Psychiatry · doi:10.1016/j.biopsych.2022.02.010 · Cited by 58
Wagner, J., Schoene‐Bake, J., Malter, M. P., Urbach, H., Huppertz, H., Elger, C. E., & Weber, B. (2013) · Epilepsia · doi:10.1111/epi.12320 · Cited by 50
Status Epilepticus and Refractory Status Epilepticus Management
Abend, N. S., Bearden, D. R., Helbig, I., McGuire, J. L., Narula, S., Panzer, J. A., Topjian, A., & Dlugos, D. (2014) · Seminars in Pediatric Neurology · doi:10.1016/j.spen.2014.12.006 · Cited by 50
Sinmaz, N., Amatoury, M., Merheb, V., Ramanathan, S., Dale, R. C., & Brilot, F. (2015) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12764 · Cited by 50
Neuronal autoantibodies in epilepsy patients with peri-ictal autonomic findings
Baysal-Kıraç, L., Tüzün, E., Erdağ, E., Ulusoy, C. A., Vanlı-Yavuz, E. N., Ekizoğlu, E., Peach, S., Sezgi̇n, M., Bebek, N., Gürses, C., et al. (2016) · Journal of Neurology · doi:10.1007/s00415-015-8002-2 · Cited by 51
Plasma exchange in neurological disease
Osman, C., Jennings, R., El‐Ghariani, K., & Pinto, A. A. (2019) · Practical Neurology · doi:10.1136/practneurol-2019-002336 · Cited by 50
Anti-N-Methyl-d-Aspartate Receptor Encephalitis: Early Treatment is Beneficial
Breese, E. H., Dalmau, J. O., Lennon, V. A., Apiwattanakul, M., & Sokol, D. K. (2010) · Pediatric Neurology · doi:10.1016/j.pediatrneurol.2009.10.003 · Cited by 49
Encephalitis Surveillance through the Emerging Infections Program, 1997–2010
Bloch, K. C., & Glaser, C. A. (2015) · Emerging Infectious Diseases · doi:10.3201/eid2109.150295 · Cited by 49
Autoimmune encephalitis: a potentially treatable cause of mental disorder
Rickards, H. E., Jacob, S., Lennox, B., & Nicholson, T. R. (2014) · Advances in Psychiatric Treatment · doi:10.1192/apt.bp.113.011304 · Cited by 49
Neonatal Fc Receptor–Targeted Therapies in Neurology
Nelke, C., Spatola, M., Schroeter, C. B., Wiendl, H., & Lünemann, J. D. (2022) · Neurotherapeutics · doi:10.1007/s13311-021-01175-7 · Cited by 48
Brenner, J., Ruhe, C. J., Kulderij, I., Bastiaansen, A. E. M., Crijnen, Y. S., Kret, C. N., Verkoelen, J. C. P., Tolido, A. A. G., Thomassen, B., Kersten, L. P., et al. (2024) · Neurology · doi:10.1212/wnl.0000000000210109 · Cited by 51
Anti–N-Methyl-D-Aspartate Receptor Encephalitis in Children and Adolescents
Scheer, S., & John, R. M. (2015) · Journal of Pediatric Health Care · doi:10.1016/j.pedhc.2015.09.004 · Cited by 49
NMDA receptor autoantibodies in sporadic Creutzfeldt-Jakob disease
Mackay, G. A., Ahmad, K. E., Stone, J., Sudlow, C. L. M., Summers, D. M., Knight, R., Will, R. G., Irani, S. R., Vincent, A. C., & Maddison, P. (2012) · Journal of Neurology · doi:10.1007/s00415-012-6489-3 · Cited by 49
Kröll‐Seger, J., Bien, C. G., & Huppertz, H. (2009) · Epileptic Disorders · doi:10.1684/epd.2009.0237 · Cited by 49
Cognitive and neuropsychological evolution in children with anti-NMDAR encephalitis
Matricardi, S., Patrini, M., Freri, E., Ragona, F., Zibordi, F., Andreetta, F., Nardocci, N., & Granata, T. (2016) · Journal of Neurology · doi:10.1007/s00415-016-8056-9 · Cited by 48
Elevation of YKL-40 in the CSF of Anti-NMDAR Encephalitis Patients Is Associated With Poor Prognosis
Chen, J., Ding, Y., Zheng, D., Wang, Z., Pan, S., Ji, T., Shen, H., & Wang, H. (2018) · Frontiers in Neurology · doi:10.3389/fneur.2018.00727 · Cited by 50
Coexistence of Autoimmune Encephalitis and Other Systemic Autoimmune Diseases
Zhao, J., Wang, C., Xu, X., Zhang, Y., Ren, H., Ren, Z., Li, G., Zhang, J., & Guan, H. (2019) · Frontiers in Neurology · doi:10.3389/fneur.2019.01142 · Cited by 49
Clinical analysis of anti-NMDAR encephalitis combined with MOG antibody in children
Hou, C., Wu, W., Tian, Y., Zhang, Y., Zhu, H., Zeng, Y., Peng, B., Zheng, K., Li, X., & Chen, W. (2020) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2020.102018 · Cited by 50
Bartels, F., Krohn, S., Nikolaus, M., Johannsen, J., Wickström, R., Schimmel, M., Häusler, M., Berger, A., Breu, M., Blankenburg, M. R., et al. (2020) · Annals of Neurology · doi:10.1002/ana.25754 · Cited by 51
Current Status of Biomarkers in Anti-N-Methyl-D-Aspartate Receptor Encephalitis
Ciano-Petersen, N. L., Cabezudo‐García, P., Muñiz‐Castrillo, S., Honnorat, J., Serrano-Castro, P. J., & Oliver‐Martos, B. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222313127 · Cited by 49
Seizures as first symptom of anti-NMDA receptor encephalitis are more common in men
Titulaer, M. J., & Dalmau, J. O. (2014) · Neurology · doi:10.1212/wnl.0000000000000131 · Cited by 49
Cabral-Marques, O., Moll, G., Catar, R. A., Preuß, B. E., Bankamp, L., Pecher, A., Henes, J., Klein, R., Kamalanathan, A. S., Akbarzadeh, R., et al. (2023) · Autoimmunity Reviews · doi:10.1016/j.autrev.2023.103310 · Cited by 50
N-methyl-D-aspartate Receptor Autoimmune Encephalitis Presenting With Opsoclonus-Myoclonus
Smith, J. H. (2011) · Archives of Neurology · doi:10.1001/archneurol.2011.166 · Cited by 47
Differences in treatment of anti-NMDA receptor encephalitis: results of a worldwide survey
Bartolini, L., & Muscal, E. (2017) · Journal of Neurology · doi:10.1007/s00415-017-8407-1 · Cited by 48
Reversible limbic encephalitis with antibodies against the membranes of neurones of the hippocampus
Shimazaki, H., Ando, Y., Nakano, I., & Dalmau, J. O. (2006) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2006.104513 · Cited by 48
Greenlee, J., Carlson, N. G., Abbatemarco, J., Herdlevær, I., Clardy, S. L., & Vedeler, C. A. (2022) · Frontiers in Neurology · doi:10.3389/fneur.2021.744653 · Cited by 47
Marsili, L., Marcucci, S., LaPorta, J., Chirra, M., Espay, A. J., & Colosimo, C. (2023) · Biomedicines · doi:10.3390/biomedicines11051406 · Cited by 47
Bodansky, A., Yu, D. J. L., Rallistan, A., Kalaycıoğlu, M., Boonyaratanakornkit, J. B., Green, D. J., Gauthier, J., Turtle, C. J., Zorn, K. C., O’Donovan, B. D., et al. (2024) · Journal of Clinical Investigation · doi:10.1172/jci180012 · Cited by 55
Höftberger, R., Armangué, T., Leypoldt, F., Graus, F., & Dalmau, J. O. (2013) · Clinical Neuropathology · doi:10.5414/np300666 · Cited by 47
Aranow, C. B., Diamond, B., & Mackay, M. C. (2010) · Rheumatic Disease Clinics of North America · doi:10.1016/j.rdc.2009.12.007 · Cited by 46
Bakpa, O. D., Reuber, M., & Irani, S. R. (2016) · Seizure · doi:10.1016/j.seizure.2016.07.002 · Cited by 47
Remy, K. E., Custer, J. W., Cappell, J., Foster, C. B., Garber, N. A., Walker, L. K., Simon, L., & Bagdure, D. N. (2017) · Frontiers in Pediatrics · doi:10.3389/fped.2017.00250 · Cited by 48
Wang, R., Lai, X., Liu, X., Li, Y., Chu, C., Li, C., Chi, X., Zhou, D., & Hong, Z. (2017) · Journal of Neurology · doi:10.1007/s00415-017-8707-5 · Cited by 47
Zhang, Y., Liu, G., Jiang, M., Chen, W., & Su, Y. (2019) · Neurotherapeutics · doi:10.1007/s13311-019-00725-4 · Cited by 47
Metadata
- Authors
- Dalmau, J., Tüzün, E., Wu, H., Masjuan, J., Rossi, J. E., Voloschin, A., Baehring, J. M., Shimazaki, H., Koide, R., King, D., Mason, W., Sansing, L. H., Dichter, M. A., Rosenfeld, M. R., & Lynch, D. R.
- Affiliations
- University of Pennsylvania (US)
- Augusta University (US)
- Yale University (US)
- Jichi Medical University (JP)
- Tokyo Metropolitan Neurological Hospital (JP)
- Children's Hospital of Pittsburgh (US)
- Princess Margaret Cancer Centre (CA)
- Corresponding author
- Dalmau, Josep
- ORCID
- Venue
- Annals of Neurology
- Publisher
- Wiley
- Published
- 2007-01
- Volume
- 61
- Issue
- 1
- Pages
- 25-36
- ISSN
- 0364-5134 (ISSN-L)
- 1531-8249
- PMC
- PMC2430743
- OpenAlex
- W2114398221
- Cited by
- 2,492
- References
- 37
- Citations by year
- 2026: 105 · 2025: 122 · 2024: 142 · 2023: 135 · 2022: 168 · 2021: 190 · 2020: 158 · 2019: 179 · 2018: 128 · 2017: 152 · 2016: 158 · 2015: 145 · 2014: 129 · 2013: 143 · 2012: 113
- FWCI
- 47.94
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Annals of Neurology (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Cancer Institute (R01CA089054, R01CA107192)
- National Institute of Neurological Disorders and Stroke (R01NS045986)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Autoimmune Neurological Disorders and Treatments
- Health Sciences › Medicine › Clinical Neurology › Peripheral Neuropathies and Disorders
- Health Sciences › Medicine › Clinical Neurology › Myasthenia Gravis and Thymoma
- Keywords
- paraneoplastic encephalitis, anti-NMDA receptor encephalitis, ovarian teratoma, NMDA receptor subunits, NR2B, NR2A, autoantibodies, hippocampal neurons, autoimmune encephalitis, tumor resection, immunotherapy, microglial activation, neurodegeneration, psychiatric symptoms, amnesia, seizures
- MeSH terms
- Adolescent, Adult, Animals, Antibodies, Dissection, Encephalitis, Female, Humans, Immunohistochemistry, Immunosuppressive Agents, Magnetic Resonance Imaging, Male, Neurons, Ovarian Neoplasms, Teratoma, Transfection, Gene Expression Regulation, Neoplastic, Receptors, N-Methyl-D-Aspartate, Treatment Outcome, Rats, Wistar, Protein Subunits, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
